Absence seizures are brief, sudden interruptions of consciousness in children — staring spells of 5–20 seconds that look like daydreaming but are dozens of seizures per day. Highly treatable with the right diagnosis. Expert paediatric epilepsy care at KIMS Neuroscience, Secunderabad, Hyderabad.
Brief, sudden episodes of staring and unawareness — 5–20 seconds — that stop abruptly with no confusion
Typically 4–10 years for Childhood Absence Epilepsy
10–100 absence seizures per day in active, untreated cases
Inattention, daydreaming, ADHD, or behavioural problem — regularly missed for 1–3 years
EEG with hyperventilation — the characteristic 3Hz spike-and-wave discharge is produced reliably
Ethosuximide — achieves seizure freedom in approximately 53–58% at 16 weeks, higher with dose titration
78.8% achieve seizure remission overall; approximately 70% outgrow it by adolescence
Carbamazepine actively worsens absence seizures — it is contraindicated
Paediatric Neurology · Epilepsy
040-44885000
Absence seizures are brief, sudden interruptions of consciousness — staring spells of 5–20 seconds in which the child stops, does not respond to their name, and resumes immediately on recovery with no memory of the episode. In active Childhood Absence Epilepsy (CAE), 10–100 seizures occur per day. They are regularly dismissed as daydreaming for 1–3 years while the child falls progressively behind academically. The EEG with hyperventilation produces the diagnostic 3Hz spike-and-wave discharge within minutes. The correct medication (ethosuximide) achieves seizure freedom in most children. 78.8% achieve remission; ~70% outgrow the condition by adolescence. Carbamazepine specifically worsens absence seizures and is contraindicated.
| Fact | Details |
|---|---|
| Definition | Brief (5–20 sec) generalised seizure · Abrupt onset and offset · No postictal confusion · 10–100 per day in active cases · Child has no memory |
| Diagnostic test | EEG with hyperventilation · 3Hz spike-and-wave provoked in virtually every active case · Safe, 30-minute test · Same-week at KIMS |
| First-line medication | Ethosuximide (pure absence) · Valproate (absence + tonic-clonic) · Lamotrigine (alternative) · 2010 NEJM RCT: ethosuximide superior attentional outcomes |
| Contraindicated medications | Carbamazepine · Oxcarbazepine · Phenytoin · Vigabatrin · Phenobarbitone · Gabapentin — all worsen absence seizures |
| Prognosis | 78.8% seizure remission overall · ~70% outgrow by adolescence · Medication withdrawal only under supervised EEG guidance at KIMS |
| School impact | KIMS school liaison letters for every child · Neuropsychological assessment for persistent academic difficulty · Do not discipline child for apparent inattention during seizures |
| When to seek KIMS | Staring spells in a child · Seizures worsening on current medication · ADHD diagnosis not improving · No EEG yet done · Carbamazepine with worsening spells |
Note: Absence seizures themselves are not emergencies — they end on their own within seconds. However, if a staring episode lasts more than 30 seconds without resolving, or if seizures follow one after another without recovery in between — call 040-46324365 immediately.
A class teacher in Hyderabad writes in a student's report: "Does not pay attention. Frequently stares into space during lessons. Needs to be called multiple times to respond. Appears to daydream excessively."
The parents discuss it at home. The child seems fine otherwise — good at sports, happy with friends, no behaviour problems at home. They speak to the child, who cannot explain the inattention. They try to observe more carefully at the dinner table. And one evening — they see it.
Mid-sentence, the child's eyes glaze over. The fork stops moving. For about 10 seconds, the child is gone — not responding to their name, not blinking normally, staring at nothing. Then, without warning, the child resumes eating and continues their sentence from exactly where it stopped — unaware that anything happened.
This is an absence seizure. And this child, whose academic performance has been declining for a year, has been having 30–50 of these every day.
Absence seizures are one of the most commonly missed diagnoses in paediatric neurology across India. They are missed because they look like nothing alarming. They do not involve falling, convulsing, or crying out. They produce no pain, no confusion, and no memory of the episode in the child. From the outside, they look like inattention, daydreaming, or distraction. Children are labelled as unfocused, poorly motivated, or having ADHD — for months or years — while having dozens of seizures every single day.
The cost of this diagnostic delay is real. A child having 50 absence seizures daily is missing significant portions of classroom instruction, losing conversational threads, failing to process continuous information, and falling behind academically — not because of any intellectual or behavioural problem, but because of epilepsy.
The treatment is straightforward. A 5-minute EEG with hyperventilation is both diagnostic and conclusive. The correct medication — typically ethosuximide — controls seizures in the majority of children. Most children outgrow the condition entirely by adolescence. There is no good reason for absence epilepsy to go undiagnosed for two years.
At KIMS Neuroscience, Secunderabad, Hyderabad, absence seizures are diagnosed with same-week EEG. The correct medication is started at the first consultation. And the family leaves understanding, for the first time, why their child has been struggling at school.
Same-week EEG appointments for children with suspected absence epilepsy at KIMS Neuroscience Hyderabad.
040-44885000International enquiries neuroscience@kimshospitals.comAn absence seizure is a brief, sudden interruption of consciousness caused by a burst of generalised abnormal electrical activity in the brain — specifically, the characteristic 3Hz (three-per-second) spike-and-wave discharge that begins and ends abruptly, engaging both hemispheres of the brain simultaneously.
The word "absence" captures the experience precisely: the child is briefly absent — not there, not aware, not responding — and then returns, completely abruptly, as though nothing happened.
The child:
• Suddenly stops whatever they are doing mid-sentence, mid-movement
• Stares blankly — eyes may glaze over, drift upward slightly, or flutter rapidly (rhythmic upward movement of the eyelids is called eyelid myoclonia and is common in absence epilepsy)
• Does not respond to their name, to touch, or to a command
• May make subtle lip-smacking or swallowing movements
• Duration: typically 5–20 seconds — rarely longer than 30 seconds
• Stops as abruptly as it started — resuming the interrupted activity immediately and precisely where it left off
• Has no memory of the episode
The absence seizure does not involve falling. It does not involve convulsing. It does not involve the postictal confusion and exhaustion that follow a tonic-clonic seizure. Recovery is immediate — complete within one second of the seizure ending. This instant recovery — combined with the brevity and the lack of any dramatic motor features — is precisely what makes absence seizures so easy to dismiss as inattention. A child who does not respond to their name for 15 seconds and then immediately responds normally does not trigger the alarm that a child who falls and convulses does.
In active, untreated childhood absence epilepsy, seizures occur frequently — often 10–100 times per day. Episodes may be so frequent that a child never goes more than a few minutes without one. The cumulative time spent in absence each school day — absent, unreachable, missing the lesson — can amount to minutes or even tens of minutes of total lost consciousness.
Several factors reliably increase absence seizure frequency:
• Hyperventilation — breathing fast or deeply (which is why blowing a candle, playing a wind instrument, or crying can trigger clusters of absences)
• Drowsiness — particularly the transition from wakefulness to light sleep, or the drowsy period after waking
• Prolonged mental inactivity — watching television or daydreaming
• Illness or fever — non-specifically increase seizure frequency
Conversely, active mental engagement — reading, solving a problem, focused conversation — typically reduces absence frequency. This creates an apparent paradox: a child who seems more attentive when engaged with an interesting task is not inconsistent with absence epilepsy.
Absence seizures occur in several distinct epilepsy syndromes — each with a different prognosis, a different likelihood of remission, and slightly different medication implications.
Onset typically at 4–10 years (peak at 5–7). Multiple absence seizures per day. Neurologically normal child, normal development and intelligence. A strong family history of epilepsy in approximately 30% of cases. The EEG shows the characteristic, regular 3Hz generalised spike-and-wave discharge — provoked reliably by hyperventilation.
CAE has an excellent prognosis. 78.8% of children with CAE achieve seizure remission with correct treatment. Approximately 70% of children outgrow it completely by adolescence and can discontinue medication. The key conditions for this excellent outcome are: correct diagnosis (not misdiagnosed as ADHD or behavioural), correct medication (not carbamazepine), and consistent medication adherence.
Onset in adolescence — 10–17 years. Absence seizures are less frequent per day than CAE, but tonic-clonic seizures are more common. Prognosis for remission is lower than CAE — many patients continue into adulthood. Treatment is similar but valproate is typically preferred because it covers both the absence and the tonic-clonic seizures.
Approximately one-third of JME patients also have absence seizures alongside the characteristic morning myoclonic jerks. Treatment for JME — valproate, levetiracetam — covers the absence component. See our dedicated Generalised Epilepsy page for the full JME discussion.
Atypical absences — slower onset and offset, more prominent motor components, associated with other seizure types — occur as part of severe epilepsy syndromes such as Lennox-Gastaut Syndrome. These are treated very differently from typical CAE. They are less responsive to ethosuximide and require polypharmacy approaches. Distinguishing typical from atypical absences on EEG (regular 3Hz vs slow, irregular, less than 2.5Hz spike-wave) is the key diagnostic discriminator.
A specific syndrome combining frequent, brief absence-like episodes with prominent eyelid fluttering — strongly provoked by eye closure in bright light (photosensitivity). Jeavons syndrome often persists into adulthood and requires careful medication management. It can be identified on EEG with photic stimulation and eye-closure testing — both performed routinely at KIMS.
A rarer, more severe syndrome where each absence is accompanied by rhythmic myoclonic jerks — typically of the shoulders and upper arms — during the episode. More likely to be treatment-resistant than typical CAE. Associated with cognitive difficulties in some patients.
Two patterns recur in the KIMS epilepsy clinic among children referred with undiagnosed absence epilepsy.
A child aged 6–8 years, referred by the school for ADHD assessment or behavioural review. Parents report that the child often "doesn't listen," "spaces out," "needs to be called multiple times." The referring doctor had tested for ADHD, started behaviour therapy, and changed the school seating arrangement — all without improvement. The possibility of epilepsy was never considered because there were no convulsions, no falls, no dramatic events.
At KIMS, a 5-minute EEG with hyperventilation produces the characteristic 3Hz discharge. The parents, watching the recording, immediately recognise the staring episode captured on video as exactly what they have been seeing at home. The child has been having absence seizures for two years.
A child referred to KIMS after 6–12 months of carbamazepine for "epilepsy" — prescribed after a parent described staring episodes to a general practitioner. The absence seizures have increased since starting carbamazepine. The dose has been raised. The seizures are now more frequent than before treatment.
Inappropriate use of carbamazepine in typical absence seizures is specifically documented in the medical literature — carbamazepine exacerbates absence epilepsy in children and adolescents. This is not a rare or exceptional event. It is one of the most consistently documented prescribing errors in paediatric epilepsy, and it is common in India because carbamazepine is the default available antiepileptic in most general practice and tier-2 hospital settings.
At KIMS, the first action when a child presents on carbamazepine with worsening absence seizures is medication review — confirm the diagnosis by EEG, stop carbamazepine, start ethosuximide. The seizures typically improve within weeks.
In many parts of Hyderabad, Telangana, and across India, EEG services are not available promptly in primary care settings. Referral pathways to paediatric neurology often take months. By the time a child reaches specialist assessment, they may have been having absence seizures for 1–3 years. At KIMS Neuroscience, same-week EEG appointments are available for children with suspected absence epilepsy — because early diagnosis changes the academic and developmental trajectory.
The most important diagnostic step happens before any test. The clinical history of childhood absence epilepsy is recognisable — brief, abrupt staring episodes, multiple times per day, no warning, immediate full recovery, no memory of the episode, triggered by hyperventilation. When these features are described by the parent, the diagnosis is strongly suspected before the child enters the EEG room.
The history also establishes: age of onset, frequency, any associated features (eyelid fluttering, lip movements, brief jerks), the presence of any tonic-clonic seizures, academic impact, and family history of epilepsy.
In CAE, the neurological examination between seizures is completely normal — normal intelligence, normal development, normal motor function. The absence of any neurological abnormality between seizures is an important feature of the typical absence epilepsy syndromes.
A key bedside observation during the consultation: the child is asked to breathe rapidly and deeply for 3 minutes — hyperventilation. In active absence epilepsy, this reliably provokes an absence seizure within 1–3 minutes of starting hyperventilation. The clinician watches the child stare and become unresponsive — and the family, who may have been told for months that nothing is wrong, watches their child have a seizure in front of the doctor. This is often one of the most clarifying moments in the diagnostic journey.
The EEG is both diagnostic and quantitative in childhood absence epilepsy.
What the EEG shows: The 3Hz generalised spike-and-wave discharge — a regular, symmetric pattern occurring simultaneously in all EEG channels at exactly three discharges per second. The discharge begins abruptly, is completely regular throughout, and ends as abruptly as it started. During the discharge, the child stares and is unresponsive — and if the EEG is correlated with video, the clinical absence and the EEG discharge are precisely simultaneous.
How it is provoked: Hyperventilation during the EEG recording — standard in every paediatric EEG at KIMS — reliably provokes the discharge in virtually every child with active absence epilepsy. In some cases, photic stimulation (flashing lights) also provokes discharges.
The diagnostic value: A normal EEG with a 3-minute hyperventilation does not exclude absence epilepsy in a child who is not having frequent seizures at the time of recording. A sleep-deprived EEG or ambulatory EEG (home EEG recording over 24 hours) is performed when the routine EEG is normal despite strong clinical suspicion.
The family's role in the EEG: At KIMS, parents and carers are invited into the EEG room during the hyperventilation phase. When the child has a captured absence seizure on EEG — visible on the screen as the typical discharge, visible on video as the child staring and not responding — and the parent says, "That's exactly what happens at home" — the diagnosis is confirmed and the family's understanding changes immediately. The mystery of months or years is resolved in minutes.
Typical childhood absence epilepsy syndromes (CAE, JAE) have completely normal MRI — the epilepsy is genetic in origin, not structural. MRI is nevertheless performed at KIMS to exclude structural causes, particularly if the clinical presentation is atypical or if the EEG shows features suggesting a more complex syndrome.
In cases of childhood absence epilepsy pharmacoresistant to standard medications, GLUT-1 (glucose transporter type 1) deficiency must be excluded — especially if absences started before the age of four years or if neurological signs are present. GLUT-1 deficiency is a rare but important cause of early-onset absence epilepsy that responds dramatically to the ketogenic diet (which bypasses the glucose transport defect by providing ketones as an alternative brain fuel). At KIMS, GLUT-1 testing (CSF glucose and genetic testing for SLC2A1 mutations) is offered for very early-onset or medication-resistant absences.
The treatment of choice for CAE with absence seizures only is ethosuximide. Valproic acid and lamotrigine are also effective treatments, but when compared to ethosuximide, valproic acid has more adverse effects and lamotrigine is less effective.
Ethosuximide: The first-line medication for CAE with absence seizures as the only seizure type. In the landmark 2010 randomised controlled trial of 453 children, ethosuximide and valproic acid had similar seizure freedom rates (53% and 58% respectively) but ethosuximide had superior attentional outcomes — making it the preferred choice, particularly because children with absence epilepsy frequently have pre-existing attention difficulties. Available in syrup form, which is preferred for young children. Ethosuximide does not protect against generalised tonic-clonic seizures — if a child has both absence and tonic-clonic seizures, valproate is preferred.
Valproate (sodium valproate): Effective for both absence seizures and generalised tonic-clonic seizures — the preferred choice when both seizure types are present. Important caution: valproate requires careful counselling in adolescent girls regarding teratogenic risk (covered in the Generalised Epilepsy page). In pre-adolescent children without this concern, valproate is a fully appropriate choice.
Lamotrigine: Effective but less potent than ethosuximide or valproate for absence seizure control — used when ethosuximide causes intolerable side effects and valproate is not appropriate.
Carbamazepine: Contraindicated. Sodium channel-blocking drugs worsen absence seizures. Carbamazepine can dramatically increase absence seizure frequency, including provoking absence status epilepticus in susceptible patients.
Oxcarbazepine: Same mechanism as carbamazepine — contraindicated in absence epilepsy.
Phenytoin: Contraindicated in absence epilepsy.
Vigabatrin: Documented to worsen absence seizures.
Phenobarbitone: Does not effectively control absence seizures in most patients and causes significant sedation and cognitive slowing in children — should not be used.
Gabapentin and pregabalin: Not indicated for absence epilepsy and may worsen it.
At KIMS, every child referred on one of the contraindicated medications with worsening absence seizures has the medication changed immediately at the first consultation.
Ethosuximide is started at 10–15 mg/kg/day divided into two doses and titrated upward every 1–2 weeks until seizures are controlled, to a maximum of 40 mg/kg/day. The titration is guided by seizure diary and EEG monitoring. Most children achieve control within 6–8 weeks of reaching the therapeutic dose.
Duration of treatment: Medication is continued for at least 2 years of complete seizure freedom before withdrawal is considered in CAE. The withdrawal is supervised, gradual, and guided by EEG. At KIMS, the EEG is repeated before any withdrawal plan is initiated — if epileptiform discharges persist even in the absence of clinical seizures, withdrawal is deferred.
Pharmacoresistance occurs in 20–30% of childhood absence epilepsy patients. When ethosuximide, valproate, and lamotrigine in monotherapy and then combination have all failed, more complex approaches are considered at KIMS:
• The valproate + ethosuximide combination often achieves control when either alone fails
• GLUT-1 deficiency is excluded and ketogenic diet initiated if confirmed
• Broad-spectrum antiepileptics such as topiramate or zonisamide may be added
• Clobazam as adjunctive therapy
A child having 50 absence seizures per day is having those seizures during lessons, during conversations with friends, during examinations, and during extracurricular activities. Each seizure lasts 5–20 seconds — but the interruption to cognitive processing extends slightly beyond the seizure itself. A child processing a maths explanation who blanks out for 10 seconds in the middle may miss the key logical step and find the rest of the lesson incomprehensible. Multiply this by dozens of episodes a day, across years, and the cumulative academic damage is significant.
• Inform the school in writing — KIMS provides a written school liaison letter for every child diagnosed with absence epilepsy
• The letter explains: the diagnosis, what an absence seizure looks like, how long it lasts, what to do (nothing — stay with the child, wait for recovery), how the teacher can help (seat the child near the front, check comprehension after apparent blank episodes, allow extra time in examinations)
• Ask the school not to discipline the child for apparent inattention during seizures
• Keep a seizure diary — noting frequency, timing, and triggers
Every child diagnosed at KIMS with a seizure condition affecting school function receives a written letter addressed to the school — explaining the diagnosis in plain language, the expected impact on classroom learning, and the recommended accommodations. This letter can be decisive in protecting the child from unfair academic penalties and in ensuring teacher awareness and appropriate support.
For children with persistent absence epilepsy or academic difficulties beyond what seizure frequency alone would explain — neuropsychological assessment at KIMS identifies the specific cognitive profile, guides educational support planning, and distinguishes epilepsy-related cognitive effects from co-existing conditions such as genuine ADHD, learning disability, or anxiety.
For Childhood Absence Epilepsy:
CAE has an excellent prognosis with correct treatment. 78.8% of children with CAE achieve seizure remission overall, with only 4% experiencing further seizures after treatment discontinuation in long-term follow-up. Approximately 70% of children achieve sustained remission by adolescence and can eventually discontinue medication. The child who had 50 seizures a day in primary school, correctly diagnosed and treated, will in most cases be seizure-free and medication-free by age 16.
For Juvenile Absence Epilepsy:
A lower rate of remission than CAE — many patients continue into adulthood. Most continue on medication long-term. The absence seizures are often well-controlled, and quality of life is good.
The catch — when seizures appear to have resolved but medication is stopped:
The most common mistake with childhood absence epilepsy is stopping medication too soon. A child who has been seizure-free for 6 months feels cured — parents stop the medication, or the child stops independently. In a proportion of patients, seizures return — sometimes months later, sometimes years later when JME develops (absence evolving to JME is a recognised trajectory in some patients). At KIMS, the process of medication withdrawal is supervised, gradual, guided by EEG, and done at a clinically chosen time — not at the family's discretion.
Related Conditions
Explore related epilepsy and seizure disorders commonly associated with generalised epilepsy syndromes:
Your child's "daydreaming" may be absence epilepsy. A 30-minute EEG will tell you.
Absence seizures are one of the most commonly missed diagnoses in paediatric neurology in Hyderabad and across India. They look like inattention. They damage school performance quietly, every day. The diagnosis is made with a simple EEG. The treatment — the right medication — works extremely well. Come to KIMS Neuroscience, Secunderabad for a same-week EEG assessment if your child has recurring staring spells that they cannot remember.
neuroscience@kimshospitals.com